Dr. Natallia Katenka is currently an Associate Professor in the Department of Computer Science and Statistics in the College of Arts and Science at the University of Rhode Island. She also holds a limited joint appointment in the Department of Pharmacy Practice in the College of Pharmacy and is co-founder of a Networks and Causal Inference for Public Health and Education Research (NCIPHER) lab at the College of Pharmacy. The primary goals and projects of the lab fall at the intersection of causal inference methodology and novel inference and modeling methods in network science and aimed to solve critical challenges in public health research. The lab is primarily funded by NIH grant (1DP2DA046856-01) Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2). Dr. Katenka has over decade of experience in the analysis, inference, and modeling of various networks and network processes. While being interested in various types of networks (including computer network, social networks, etc.) during the past three years, her research has been enriched by studies in HIV/AIDS networks. Her most recent project aims to develop a cutting-edge stochastic network-based modeling framework for SARS-CoV-2 transmission in New York City that would help to inform the type and timing of non-pharmaceutical interventions in the area considering demographic composition (i.e., age, household size), racial disparities in health, and socioeconomics. Dr. Natallia Katenka received her B.Sc. (Summa Cum Laude) in Computer Science and her M.Sc. in Applied Mathematics from Belarusian State University in 2003 and 2004, respectively. She completed her Ph.D. degree in Statistics from the University of Michigan - Ann Arbor in 2009. She joined the University of Rhode Island in 2012, where she is currently an Associate Professor in the Department of Computer Science and Statistics. She actively collaborates with other departments at the university and also with the Department of Business at Hamburg University of Applied Sciences.
She/her/hers
United States
Germany
Greece
Buchanan A, Pearsall C, Kogut S, Bratberg J, Hogan J, Friedman SR, Katenka N. (2026). Study Design, Methods, and Modeling in Networks to Inform HIV Interventions and Policy in Marginalized Populations. Rhode Island medical journal (2013), 109(7)
Martínez-Silva ML, Ahorklo RM, Reedich EJ, Imhoff-Manuel RD, Katenka N, Manuel M. (2026). Machine-learning classification of motor unit types in the adult mouse. The Journal of physiology
Genry LT, Marble CW, Moline BC, McGinnis PJ, Kramer C, Matson S, Reedich EJ, Mena Avila E, Santos T, Dowaliby L, Katenka N, Manuel M, Quinlan KA, Detloff MR. (2026). Aberrant Pain Phenotypes Emerge Following Prenatal Hypoxic-Ischemic Injury in a Rabbit Model of Cerebral Palsy. bioRxiv : the preprint server for biology
Skov B, Buchanan AL, Katenka NV, Hoque Nadia T, Friedman SR, Nikolopoulos GK. (2025). Evaluation of the Relationship Between Network Centrality and Individual Sociodemographics and Behaviors Among People Who Inject Drugs. Substance use & misuse
Ryan V, Lee T, Piovani D, Katenka N, Friedman SR, Bonovas S, Buchanan A, Nikolopoulos G. (2025). Attributes Associated with HIV Risk Behaviors in a Network-Based Study of People Who Inject Drugs. Current HIV research
Lee T, Buchanan AL, Katenka N, Forastiere L, Halloran ME, Nikolopoulos G. (2025). Assessing spillover effects: Handling missing outcomes in network-based studies. Statistical methods in medical research
Nikolopoulos G, Buchanan A, Katenka N, Bonova E, Pantavou K, Piovani D, Zhang K, Bonovas S, Friedman SR, Fokianos K. (2025). Evaluation of spill-over effects of antiretroviral treatment on sharing injecting equipment in a sociometric network of people who inject drugs. AIDS care, 37(8)
Jean Gregoire M, Sirtori R, Donatelli L, Morgan Potts E, Collins A, Zamor D, Katenka N, Fallini C. (2024). Early disruption of the CREB pathway drives dendritic morphological alterations in FTD/ALS cortical neurons. Proceedings of the National Academy of Sciences of the United States of America, 121(49)
Puleo J, Buchanan A, Katenka N, Halloran ME, Friedman SR, Nikolopoulos G. (2024). Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject Drugs. Stats, 7(2)
Buchanan AL, Katenka N, Lee Y, Wu J, Pantavou K, Friedman SR, Halloran ME, Marshall BDL, Forastiere L, Nikolopoulos GK. (2023). Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs. Pathogens (Basel, Switzerland), 12(2)
Lee Y, Buchanan AL, Ogburn EL, Friedman SR, Halloran ME, Katenka NV, Wu J, Nikolopoulos GK. (2023). Finding influential subjects in a network using a causal framework. Biometrics
Lee T, Buchanan AL, Katenka NV, Forastiere L, Halloran ME, Friedman SR, Nikolopoulos G. (2023). Estimating Causal Effects of HIV Prevention Interventions with Interference in Network-based Studies among People Who Inject Drugs. The annals of applied statistics, 17(3)
Sun T, Katenka N, Kogut S, Bratberg J, Rich J, Buchanan A. (2022). Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology, 1(3)
Buchanan AL, Park CJ, Bessey S, Goedel WC, Murray EJ, Friedman SR, Halloran ME, Katenka NV, Marshall BDL. (2022). Spillover Benefit of Pre-Exposure Prophylaxis for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model. Epidemiology and infection
Cavarsan CF, Steele PR, Genry LT, Reedich EJ, McCane LM, LaPre KJ, Puritz AC, Manuel M, Katenka N, Quinlan KA. (2023). Inhibitory interneurons show early dysfunction in a SOD1 mouse model of amyotrophic lateral sclerosis. The Journal of physiology, 601(3)
Aroke H, Katenka N, Kogut S, Buchanan A. Network-based Analysis of Prescription Opioids Dispensing Using Exponential Random Graph Models (ERGMs). Complex Networks & Their Applications X. Volume 2 : proceedings of the Tenth International Conference on Complex Networks and Their Applications COMPLEX NETWORKS 2021. International Conference on Complex Networks and Their Applications ..., (1016)
Aroke H, Buchanan A, Katenka N, Crawford FW, Lee T, Halloran ME, Latkin C. (2022). Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs. AIDS and behavior
Sun T, Aroke H, Kogut S, Katenka N, Bratberg J, Buchanan A. (2021). Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits and healthcare cost compare to late initiation. The American journal of drug and alcohol abuse
Marchenko O, Tsodikov A, Keener R, Katenka N, Kloster Thomas Y. (2017). Joint modeling of time to recurrence and cancer stage at recurrence in oncology trials. Journal of biopharmaceutical statistics, 27(3)
Adochite RC, Moshnikova A, Golijanin J, Andreev OA, Katenka NV, Reshetnyak YK. (2016). Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes. Molecular imaging and biology, 18(5)
Antosh MP, Wijesinghe DD, Shrestha S, Lanou R, Huang YH, Hasselbacher T, Fox D, Neretti N, Sun S, Katenka N, Cooper LN, Andreev OA, Reshetnyak YK. (2015). Enhancement of radiation effect on cancer cells by gold-pHLIP. Proceedings of the National Academy of Sciences of the United States of America, 112(17)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.